par Alkhateeb, Sultan;Neill, Mischel;Bar-Moshe, Sas;Rhijn, Bas Van;Kakiashvili, David M;Fleshner, Neil E.;Jewett, Michael A.S.;Petein, Michel ;Schulman, Claude ;Hanna, Sally;Bostrom, Peter J;Roumeguere, Thierry ;Shariat, Shahrokh F.;Rorive, Sandrine ;Zlotta, Alexandre
Référence Urology Annals, 3, 3, page (119-126)
Publication Publié, 2011-09
Référence Urology Annals, 3, 3, page (119-126)
Publication Publié, 2011-09
Article révisé par les pairs
Résumé : | To evaluate the long-term prognostic value of the combination of the EORTC risk calculator and proapoptotic, antiapoptotic, proliferation, and invasiveness molecular markers in predicting the outcome of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) treated with intravesical Bacille Calmette-Guérin (BCG) therapy. |